Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type

BackgroundVariants in membrane-bound transcription factor peptidase, site 1 (MBTPS1) gene, can result in clinically rare spondyloepiphyseal dysplasia of Kondo-fu type (OMIM #618392, SEDKF), Silver–Russell syndrome, and CAOP (cataract, alopecia, oral mucosal disorder, and psoriasis-like) syndrome.Cas...

Full description

Bibliographic Details
Main Authors: Congli Chen, Jin Wu, Ying Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1068718/full
_version_ 1811173247407882240
author Congli Chen
Congli Chen
Jin Wu
Jin Wu
Ying Liu
Ying Liu
author_facet Congli Chen
Congli Chen
Jin Wu
Jin Wu
Ying Liu
Ying Liu
author_sort Congli Chen
collection DOAJ
description BackgroundVariants in membrane-bound transcription factor peptidase, site 1 (MBTPS1) gene, can result in clinically rare spondyloepiphyseal dysplasia of Kondo-fu type (OMIM #618392, SEDKF), Silver–Russell syndrome, and CAOP (cataract, alopecia, oral mucosal disorder, and psoriasis-like) syndrome.Case presentationA 6-year-old Chinese male child diagnosed with SEDKF underwent 3 years of growth hormone therapy. A genetic examination revealed two new nonsense variants in the MBTPS1 gene on chromosome 16q23-q24 with compound heterozygotes c.1589(exon12)A > G and c.163(exon2)G > A.ConclusionThe MBTPS1 gene c.1589(exon12)A > G and c.163(exon2)G > A on chromosome 16q23-q24 is associated with SEDKF. Growth hormone therapy can repair growth retardation in patients with spondyloepiphyseal dysplasia, Kondo-Fu type; however, more evidence of such patient cases is required to support this hypothesis.
first_indexed 2024-04-10T17:44:06Z
format Article
id doaj.art-45a7496bf6fc4aa78d73c09e3edde57a
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-10T17:44:06Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-45a7496bf6fc4aa78d73c09e3edde57a2023-02-03T05:46:35ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-02-011110.3389/fped.2023.10687181068718Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu typeCongli Chen0Congli Chen1Jin Wu2Jin Wu3Ying Liu4Ying Liu5Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, ChinaDepartment of Pediatrics, West China Second Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, ChinaDepartment of Pediatrics, West China Second Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, ChinaBackgroundVariants in membrane-bound transcription factor peptidase, site 1 (MBTPS1) gene, can result in clinically rare spondyloepiphyseal dysplasia of Kondo-fu type (OMIM #618392, SEDKF), Silver–Russell syndrome, and CAOP (cataract, alopecia, oral mucosal disorder, and psoriasis-like) syndrome.Case presentationA 6-year-old Chinese male child diagnosed with SEDKF underwent 3 years of growth hormone therapy. A genetic examination revealed two new nonsense variants in the MBTPS1 gene on chromosome 16q23-q24 with compound heterozygotes c.1589(exon12)A > G and c.163(exon2)G > A.ConclusionThe MBTPS1 gene c.1589(exon12)A > G and c.163(exon2)G > A on chromosome 16q23-q24 is associated with SEDKF. Growth hormone therapy can repair growth retardation in patients with spondyloepiphyseal dysplasia, Kondo-Fu type; however, more evidence of such patient cases is required to support this hypothesis.https://www.frontiersin.org/articles/10.3389/fped.2023.1068718/fullspondyloepiphyseal dysplasiaKondo-Fu typeMBTPS1genotypephenotyperhGH therapy
spellingShingle Congli Chen
Congli Chen
Jin Wu
Jin Wu
Ying Liu
Ying Liu
Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type
Frontiers in Pediatrics
spondyloepiphyseal dysplasia
Kondo-Fu type
MBTPS1
genotype
phenotype
rhGH therapy
title Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type
title_full Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type
title_fullStr Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type
title_full_unstemmed Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type
title_short Case Report: Recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia, Kondo-Fu type
title_sort case report recombinant human growth hormone therapy in a patient with spondyloepiphyseal dysplasia kondo fu type
topic spondyloepiphyseal dysplasia
Kondo-Fu type
MBTPS1
genotype
phenotype
rhGH therapy
url https://www.frontiersin.org/articles/10.3389/fped.2023.1068718/full
work_keys_str_mv AT conglichen casereportrecombinanthumangrowthhormonetherapyinapatientwithspondyloepiphysealdysplasiakondofutype
AT conglichen casereportrecombinanthumangrowthhormonetherapyinapatientwithspondyloepiphysealdysplasiakondofutype
AT jinwu casereportrecombinanthumangrowthhormonetherapyinapatientwithspondyloepiphysealdysplasiakondofutype
AT jinwu casereportrecombinanthumangrowthhormonetherapyinapatientwithspondyloepiphysealdysplasiakondofutype
AT yingliu casereportrecombinanthumangrowthhormonetherapyinapatientwithspondyloepiphysealdysplasiakondofutype
AT yingliu casereportrecombinanthumangrowthhormonetherapyinapatientwithspondyloepiphysealdysplasiakondofutype